Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US1989/005670external-prioritypatent/WO1990008536A1/en
Application filed by Alza CorpfiledCriticalAlza Corp
Publication of NO912497D0publicationCriticalpatent/NO912497D0/en
Publication of NO912497LpublicationCriticalpatent/NO912497L/en
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Doseringsform (10) omfattende en komponent valgt blant nikardipin og farmasøytisk akseptable salter derav for admi- nistrering til en pasient som trenger kardiovaskulærterapi.Dosage form (10) comprising a component selected from nicardipine and pharmaceutically acceptable salts thereof for administration to a patient in need of cardiovascular therapy.
NO91912497A1989-01-301991-06-26
DOSAGE FORM FOR ADMINISTRATION OF CALCIUM ANTAGONIST.
NO912497L
(en)
Method of preparation of a composition comprising a medicament which is a bronchodilator and anti-inflammatory drug for the treatment and use of respiratory disorders
4-fluoro-2-//(4-methoxy-2-pyridyl)methyl/sulfinyl/ -1h - benzimidazole, process for its production and a pharmaceutical comprising said compound as an active component